Biostem

Biostem

Created using Figma
ब्लॉकचेन तकनीक के साथ संयुक्त रूप से अत्यधिक परिष्कृत जैव रासायनिक सेल प्रौद्योगिकी।

बायोस्टेम एक अत्याधुनिक तकनीक है, जिसका उद्देश्य एक विकेन्द्रीकृत मंच प्रदान करके आधुनिक दिन चिकित्सा और बायोटेक उद्योग में क्रांति लाना है, जिसका उपयोग लेनदेन गतिविधियों, ट्रैकिंग उद्देश्यों, अनुबंध निर्माण और आउटसोर्सिंग, रोगी के डेटा की निगरानी और रिकॉर्डिंग, चिकित्सा उपकरण जीवन चक्र और स्वास्थ्य सेवा के लिए किया जा सकता है। , अनुबंध विनिर्माण और नैदानिक ​​परीक्षण प्रबंधन। ऐसा करने के लिए, हम यह भी सुनिश्चित करते हैं कि आधुनिक दिन बायोटेक उत्पाद आसानी से सभी के लिए उपलब्ध हों - न केवल अमीरों के लिए - सस्ती दरों पर।
PRE SALE
1 अप्रैल 2019
30 मई 2019
100% पूरा कर लिया है
उठाया गया धन - डेटा नहीं
past
टोकन विवरण
टोकन वितरण
ICO Crowdfunding 30%
Founder Team 15%
Angel Funding 45%
Publisher 10%
स्वीकृत मुद्राएँ
ETH
संस्थान के विवरण
पंजीकृत देश
Malaysia
अतिरिक्त जानकारिया
श्रेणियाँ
मंच, प्रौद्योगिकी

के बारे में Biostem

MYK was established as a biotechnology manufacturer and Biotech Research Laboratory aiming to contribute to the world health and medical industry through globalizing biotechnology. Its main business areas are: health and medical industry, finance and industrial investment, and sophisticated technologies such as blockchain and Biotechnology. MYK regards technology as the core and quality as its life, and wholeheartedly builds the company into a world-class branded enterprise. Comprised of a world-class medical team and cutting-edge biotechnology equipment, MYK provides a global scaled advanced medical technology and research service platform. It provides world-class screening, diagnosis, treatment and rehabilitation services for oncological diseases; has built patient-centered, unique health management system; provide community-based prevention, diagnosis, treatment, rehabilitation, and health services, while also providing medical services. In addition, anti-aging services are supplemented to create a brand-new living experience; in response to the needs of an aging population and the improvement of the quality of life of residents, the company has created the “MYK Cell Bank” as an important carrier for healthy living and provides high-end international medical care. Health management, health care services and other age-based health care services should provide strength for the common people to achieve physical and mental health and a better life.

Biostem is a project by MYK aiming to revolutionize the traditional Medical and Biotechnology industry by providing a decentralized blockchain for storing patient, clinical and research record, and smart contracts like features for trustless outsourcing of Biotech contracts.

Our Mission

Biostem aims to contribute to the world health and medical industry by creating an ecosystem that would make the Patient’s Clinical Record and the Biotech Contract Outsourcing process, distributed through a decentralized blockchain, so that, anyone can have access to high end, state of the art medical diagnosis, treatment and Biotech products at ease.

Biostem

Biostem is state of the art ERC-20 Virtual Currency that allows peer to peer mode of payment and is deployed on decentralized ethereum blockchain based technology. The currency would be used for funding the research work, daily transactional activities happening within the Biostem health and financial ecosystem, for health care services and can also be used as a peer to peer exchange and store of value between users: securely, efficiently at reduced costs. Biostem will utilize ethereum blockchain technology to enhance its services to patients, hospitals, research centers and daily consumers, sellers, and merchants. This allows a level of transparency that was previously unrealized, while incentivizing users to adopt and use the platform. This will be done through the creation and use of Biostems.

Biostem टीम

सत्यापित 0%

ध्यान। एक जोखिम है जो असत्यापित सदस्य वास्तव में टीम के सदस्य नहीं हैं

Dr. Rubern
Chief Executive Officer
असत्यापित
Dawson Roland
Chief Technology Officer
असत्यापित
Kelson Beck
Chief Marketing Officer
असत्यापित
Matthew Hudson
Chief Financial Officer
असत्यापित
Catherine Harrison
Chief Operating Officer
असत्यापित
Rina
Biotech Consultant
असत्यापित
Allyson Brock
Human Resource Director
असत्यापित
Jozie Ayaz Khan
Business Development Director
असत्यापित
Brayden Parker
Biotech Research Consultant
असत्यापित
Sanjay Uttam Kharade
Business Consultant - Asia
असत्यापित

Biostem अंतिम समाचार

  • क्योंकि सूचना अद्यतन में समय के अंतर हो सकते हैं, प्रत्येक ICO परियोजना के बारे में सटीक जानकारी इसकी आधिकारिक वेबसाइट या अन्य संचार चैनलों के माध्यम से सत्यापित की जानी चाहिए।
  • यह जानकारी ICO फंडिंग में निवेश करने का सुझाव या सलाह नहीं है। कृपया संबंधित जानकारी की पूरी जांच करें और ICO भागीदारी पर निर्णय लें।
  • यदि आपको लगता है कि इस सामग्री पर सुधार किए जाने वाले मुद्दे या समस्याएं हैं, या यदि आप सूचीबद्ध होने के लिए अपनी खुद की ICO परियोजना सबमिट करना चाहते हैं, तो कृपया हमें ईमेल करें । एक>
अस्वीकरण और जोखिम की चेतावनी पढ़ें। अस्वीकरण और जोखिम चेतावनी दिखाएं